Orthopedics
216247128
Expert consensus on emergency surgery management for traumatic orthopedics under prevention and control of novel coronavirus pneumonia/ Zhong Hua Chuang Shang Za Zhi
Since December 2019, novel coronavirus pneumonia (NCP) has been reported in Wuhan, Hubei Province, and spreads rapidly to all through Hubei Province and even to the whole country. The virus is 2019 novel coronavirus (2019 nCoV) never been seen previously in human, but all the population is generally susceptible. The virus spreads through many ways and is highly infectious, which brings great difficulties to the prevention and control of NCP. Based on the needs of orthopedic trauma patients for emergency surgery and review of the latest NCP diagnosis and treatment strategy and the latest principles and principles of evidence based medicine in traumatic orthopedics, the authors put forward this expert consensus to systematically standardize the clinical pathway and protective measures of emergency surgery for orthopedic trauma patients during prevention and control of NCP and provide reference for the emergency surgical treatment of orthopedic trauma patients in hospitals at all levels. Key words: Coronavirus infections; Pneumonia; Fractures, bone; Surgical procedures, operative; Expert consensus
Jing Liu Hui Li Wu Zhou Guo-hui Liu Yingze Zhang Baoguo Jiang Peifu Tang Guodong Liu Xin-bao Wu Zhi-lan Yuan Fangzhu Zhou Tianbing Wang Zhong-guo Fu Zhiyong Hou Jiacan Su Bin Yu Zengwu Shao Tian Xia Liming Xiong Yue-wan Fang Guang-lin Wang Peng Lin Yanxi Chen Jiang Ni Lei Yang Dongliang Wang Chengjian He Ximing Liu Biao Che Yaming Li Junwen Wang Ming Chen Mengli Zhao Fa-qi Cao Yun Sun Bobin Mi Mengfei Liu Yuan Xiong Hang Xue Liangcong Hu Yiqiang Hu Lang Chen Chenchen Yan
219115178
The Application of a Reduced Dye Used in Orthopedics as a Novel Treatment against Coronavirus (COVID 19) A Suggested Therapeutic Protocol.
The severe acute respiratory syndrome caused by COVID 19 is now a global catastrophic event. Currently there is no approved drug or vaccine for the disease. Methylene blue (MB, oxidized form, blue color) has been used in many different areas of clinical medicine, ranging from malaria to orthopedics. Leucomethylene Blue (reduced form of MB, colorless) may be applied for the treatment of COVID 19 according to the scientific evidences. In severe patients, there is a cytokine storm (hyperinflammation) and high oxidative stress (OS) Inflammation and OS has a mutual correlation and exacerbate each other. In human body, MB first induces OS through absorbing electron (like a free radical) from other molecules, if the body could counteract to this OS, then reduced MB decreases OS through other mechanisms. Reduced MB could prevent inflammation, propagation of the virus RNA, and also improves hypoxia through reducing methemoglobin. Therefore, to avoid the increment of OS, we suggest using Leucomethylene Blue through the following protocol: The IV cocktail contains 50 mg MB (1mg/kg, 50 kg weight) 1000 2000 mg vitamin C, 500 1000 mg N Acetylcysteine (or glutathione or cysteine or a lipoic acid) and 10 20 gr urea (optional) in 100 ml dextrose 5% Before the injection, the cocktail should be kept in a dark place for 1 2 hour to become fade or colorless.
The archives of bone and joint surgery
Daryoush Hamidi Alamdari Ahmad Bagheri Moghaddam Shahram Amini Aida Hamidi Alamdari Mohammadamin Damsaz Amir Yarahmadi
220714223
COVID 19 strategy in organizing and planning orthopedic surgery in a major orthopedic referral center in an area of Italy severely affected by the pandemic: experience of the Department of Orthopedics, University of Padova
Background According to the required reorganization of all hospital activities, the recent COVID 19 pandemic had dramatic consequences on the orthopedic world. We think that informing the orthopedic community about the strategy that we adopted both in our hospital and in our Department of Orthopedics could be useful, particularly for those who are facing the pandemic later than Italy. Methods Changes were done in our hospital by medical direction to reallocate resources to COVID 19 patients. In the Orthopedic Department, a decrease in the number of beds and surgical activity was stabilized. Since March 13, it has been avoided to perform elective surgery, and since March 16, non urgent outpatient consultations were abolished. This activity reduction was associated with careful evaluation of staff and patients: extensive periodical swab testing of all healthcare staff and swab testing of all surgical patients were applied. Results These restrictions determined an overall reduction of all our surgical activities of 30% compared to 2019. We also had a reduction in outpatient clinic activities and admissions to the orthopedic emergency unit. Extensive swab testing has proven successful: of more than 160 people tested in our building, only three COVID 19 positives were found, and of over more than 200 surgical procedures, only two positive patients were found. Conclusions Extensive swab test of all people (even if asymptomatic) and proactive tracing and quarantining of potential COVID 19 positive patients may diminish the virus spread.
Journal of Orthopaedic Surgery and Research
Pietro Ruggieri Giulia Trovarelli Andrea Angelini Elisa Pala Antonio Berizzi Diego Fernando Lopez Donato
216198557
Deep Learning in Orthopedics: How Do We Build Trust in the Machine?
The paradigm of manual radiological assessment in orthopedics is at the point of significant disruption due to major breakthroughs in deep learning algorithms and computational power. Deep learning.
Alireza Borjali Antonia F Chen Orhun K Muratoglu Mohammad Amin Morid Kartik Mangudi Varadarajan
218679918
The deep impact of novel CoVID 19 infection in an Orthopedics and Traumatology Department: the experience of the Piacenza Hospital
Since February 21st, 2020 CoVID 19 spread throughout all Italy expanding like a "tsunami" from Codogno (Lodi, Lombardy, Northern Italy) to neighboring cities. In a few days Lodi, Piacenza, Milano, Brescia and Bergamo were forced to deal with this disaster starting the lockdown at different time. No national plan had been prepared. As result, CoVID 19 has paralyzed the Italian healthcare system. At time of writing, in Italy there are 169 323 infected patients and 22 260 deaths. Italy is fighting hard to manage CoVID 19 crisis even if most hospitals were unprepared to deal with massive influx of critically ill CoVID 19 patients. Piacenza in Emilia Romagna region (Northern Italy) is one of the epicenters of the Italian pandemic, and the local hospital Guglielmo da Saliceto has quickly become a "CoVID 19 hospital" with the great effort of all the medical staff. Here we report the experience of our hospital, particularly the strategy adopted in the Orthopedics and Traumatology Department. (www.actabiomedica.it)
Acta bio medica Atenei Parmensis
Pietro Maniscalco Erika Poggiali Fabrizio Quattrini Corrado Ciatti Andrea Magnacavallo Serena Caprioli Giovanni Battista Vadacca Emanuele Michieletti Luigi Cavanna Patrizio Capelli
218812477
Three dimensional printing for the accurate orthopedics: clinical cases analysis
As an emerging technology to promote the combination of medicine and industry, the three dimensional (3D) printing has developed rapidly in the fields of orthopedics, while its unique advantages in improving precise treatment still need to be further popularized. In this report, our team have exhibited several classic cases of integrating 3D printing into orthopedic clinical application, thereby further elaborating thoughts and opinions on the significance of 3D printing in the orthopedic clinical application, technical advantages, existing main problems and coping strategies.
Xie-Ping Dong Yuanwei Zhang Yanling Pei Zhe Wang Xiao-Xiang Zhang Xing-Liang Yu Zi-Zheng Ai Yu-Xiang Mei Jingna Li
216184376
Effective Management of Femur Fracture Using Damage Control Orthopedics Following Fat Embolism Syndrome
Fat embolism syndrome (FES) is a rare event following a traumatic injury, and its pathophysiologic mechanism continues to be elusive. Fat embolism syndrome generally occurs when a bone marrow fat enters the bloodstream resulting in a cascade of inflammatory response, hyper coagulation, and an array of symptoms that generally begin within 24 48 hours. FES early symptoms include petechial rash, shortness of breath, altered mental status, seizures, fever, and may result in decreased urine output. The common etiologies of a fat embolism include long bone fractures, mainly femoral and pelvic fractures. There are multiple management methods described in the literature to help prevent FES and other long bone fracture complications from occurring. Although not universally adopted, the damage control orthopedics (DCO) has been the major management option for patients with a long bone fracture. DCO is entertained by provisional immobilization of patients with long bone fractures and those who are considered severely traumatized patients (STP) Thus, immobilization can help minimize the traumatic effect and the subsequent second hit by performing non life saving surgical procedures. In this case, a patient with a transverse femur fracture suffered disconcerting symptoms of fat embolism prior to definitive femur repair. Hence, damage control orthopedics was entertained with a postponement of his femur repair to facilitate stabilization. The use of damage control orthopedics was successful in this patient with no long term complications.
Cureus
Abralena Wilson Adel Hanandeh Ahmed A Shamia Kevin Louie Brian Donaldson
210222137
Biodistribution, biocompatibility and targeted accumulation of magnetic nanoporous silica nanoparticles as drug carrier in orthopedics
Background In orthopedics, the treatment of implant associated infections represents a high challenge. Especially, potent antibacterial effects at implant surfaces can only be achieved by the use of high doses of antibiotics, and still often fail. Drug loaded magnetic nanoparticles are very promising for local selective therapy, enabling lower systemic antibiotic doses and reducing adverse side effects. The idea of the following study was the local accumulation of such nanoparticles by an externally applied magnetic field combined with a magnetizable implant. The examination of the biodistribution of the nanoparticles, their effective accumulation at the implant and possible adverse side effects were the focus. In a BALB/c mouse model (n 50) ferritic steel 1.4521 and Ti90Al6V4 (control) implants were inserted subcutaneously at the hindlimbs. Afterwards, magnetic nanoporous silica nanoparticles (MNPSNPs) modified with rhodamine B isothiocyanate and polyethylene glycol silane (PEG) were administered intravenously. Directly/1/7/21/42 day(s) after subsequent application of a magnetic field gradient produced by an electromagnet, the nanoparticle biodistribution was evaluated by smear samples, histology and multiphoton microscopy of organs. Additionally, a pathohistological examination was performed. Accumulation on and around implants was evaluated by droplet samples and histology. Results Clinical and histological examinations showed no MNPSNP associated changes in mice at all investigated time points. Although PEGylated, MNPSNPs were mainly trapped in lung, liver, and spleen. Over time, they showed two distributional patterns: early significant drops in blood, lung, and kidney and slow decreases in liver and spleen. The accumulation of MNPSNPs on the magnetizable implant and in its area was very low with no significant differences towards the control. Conclusion Despite massive nanoparticle capture by the mononuclear phagocyte system, no significant pathomorphological alterations were found in affected organs. This shows good biocompatibility of MNPSNPs after intravenous administration. The organ uptake led to insufficient availability of MNPSNPs in the implant region. For that reason, among others, the nanoparticles did not achieve targeted accumulation in the desired way, manifesting future research need. However, with different conditions and dimensions in humans and further modifications of the nanoparticles, this principle should enable reaching magnetizable implant surfaces at any time in any body region for a therapeutic reason.
Journal of Nanobiotechnology
Hilke Catherina Janssen Nina Angrisani Stefan Kalies Florian Hansmann Manfred Kietzmann Dawid Peter Warwas Peter Behrens Janin Reifenrath
210840832
Cutibacterium acnes Infection in Orthopedics: Microbiology, Clinical Findings, Diagnostic Strategies, and Management.
Cutibacterium (formerly called Propionibacterium) acnes is a human skin flora often implicated in orthopedic infections. The unique characteristics of this microorganism make the diagnosis of infection difficult. The diagnosis often is made based on clinical evidence, radiographic signs, and laboratory and/or surgical findings combined. Treatment often involves both pharmacologic and surgical methods. In addition, formation of biofilms and increased resistance to drugs exhibited by the microorganism can require combined antimicrobial therapy. Prophylactic measures are particularly important, but no single method has been shown to fully eliminate the risk of C acnes infections. Previous reports have focused on C acnes infections involving surgical implants or after certain orthopedic procedures, particularly in the shoulder and spine. This article reviews current clinical, diagnostic, and treatment principles for C acnes in orthopedics in general. [Orthopedics. 2020; 43(1):52 61.
Orthopedics
Zilan X Lin Lisa L Steed Camelia E Marculescu Harris S Slone Shane K Woolf
210982944
Improving Sexual, Racial, and Ethnic Diversity in Orthopedics: An Imperative.
Orthopedics is the least diverse medical specialty. From residents to faculty, the representation of women and underrepresented minorities lags behind that of all other specialties. The crux of the disparity stems from the pipeline, as medical students who are female and are underrepresented minorities are simply not applying to orthopedic surgery. Grassroots efforts providing early exposure to orthopedics have led to a considerable proportion of alumnae pursuing science majors and eventually medical school. Institutions with a stated commitment to diversity have successfully produced residency classes with greater diversity. The culture should be one that combats biases, dispels misconceptions about orthopedics, and prioritizes recruiting/retaining diverse providers. [Orthopedics. 2020;43(x):xx xx.
Orthopedics
James S Lin Lisa L Lattanza Kristy L Weber Julie Balch Samora